A multi-center, stratification-randomized, double-blind, placebo-controlled, phase III clinical trial of topical recombinant human thrombin for intraoperative hemostasis

被引：0

作者：

Yan, Sheng ^{[1
]}

Yu, Jun ^{[2
]}

Tu, Chaoyong ^{[3
]}

Du, Chengyou ^{[4
]}

Luo, Jia ^{[5
]}

Liu, Jingfeng ^{[6
]}

Liu, Tian-Qi ^{[7
]}

Liu, Qiang ^{[8
]}

Liu, Jun ^{[9
]}

Li, Xuehua ^{[10
]}

Wang, Lianchen ^{[11
]}

Fang, Zheping ^{[12
]}

Yi, Weimin ^{[13
]}

Chen, Yajin ^{[14
]}

Li, Qinglong ^{[15
]}

Ni, Yong ^{[16
]}

Wu, Jincai ^{[17
]}

Qin, Changjiang ^{[18
]}

Gu, Yuanlong ^{[19
]}

Lu, Zheng ^{[20
]}

Lun, Zengjun ^{[21
]}

Du, Lixue ^{[22
]}

Chen, Gang ^{[23
]}

Zheng, Qichang ^{[24
]}

Zhu, Ling ^{[25
]}

Sun, KeJian ^{[26
]}

Han, Weiqing ^{[5
]}

机构：

[1] Zhejiang Univ, Sch Med, Hosp 2, Hangzhou, Peoples R China

[2] Zhejiang Univ, Sch Med, Hosp 1, Hangzhou, Peoples R China

[3] Lishui Cent Hosp, Lishui, Peoples R China

[4] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China

[5] Hunan Canc Hosp, Changsha, Peoples R China

[6] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China

[7] Jiangbin Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China

[8] Liuzhou Peoples Hosp, Liuzhou, Peoples R China

[9] Guizhou Prov Peoples Hosp, Guiyang, Peoples R China

[10] Liaocheng Peoples Hosp, Liaocheng, Peoples R China

[11] Third Peoples Hosp Hainan Prov, Sanya, Peoples R China

[12] Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China

[13] Hunan Prov Peoples Hosp, Changsha, Peoples R China

[14] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China

[15] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China

[16] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China

[17] Hainan Prov Peoples Hosp, Haikou, Peoples R China

[18] Henan Univ, Huaihe Hosp, Kaifeng, Peoples R China

[19] Third Peoples Hosp Wuxi, Wuxi, Peoples R China

[20] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China

[21] Zaozhuang Municipal Hosp, Zaozhuang, Peoples R China

[22] Shaanxi Prov Peoples Hosp, Xian, Peoples R China

[23] First Peoples Hosp Kunming, Kunming, Peoples R China

[24] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China

[25] Wuhan Cent Hosp, Wuhan, Peoples R China

[26] Zibo Cent Hosp, Zibo, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-540

引用

页码：S488 / S488

页数：1

共 50 条

[31] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
Murakami, Masato
Osada, Kenichi
Mizuno, Hiromichi
Ochiai, Toshimitsu
Alev, Levent
Nishioka, Kusuki
ARTHRITIS RESEARCH & THERAPY, 2015, 17
[32] A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis
Chapman, William C.
Singla, Neil
Genyk, Yuri
McNeil, James W.
Renkens, Kenneth L., Jr.
Reynolds, Thomas C.
Murphy, Aileen
Weaver, Fred A.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (02) : 252 - 265
[33] Donafenib in locally advanced/metastatic, radioactive iodine-refractory, differentiated thyroid cancer: A randomized, double-blind, placebo-controlled, multi-center phase III clinical trial (DIRECTION)
Lin, Y.
Yang, H.
Shi, F.
Yang, A.
Han, X.
Liu, B.
Li, Z.
Ji, Q.
Tang, L.
Deng, Z.
Ding, Y.
Fu, W.
Xie, X.
Li, L.
He, X.
Lv, Z.
Wu, L.
Liu, L.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1294 - S1294
[34] COMPARISON OF THE ANTIANGINAL EFFICACY OF ACEBUTOLOL AND PROPRANOLOL - A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
DIBIANCO, R
SINGH, SN
SHAH, PM
NEWTON, GC
MILLER, RR
NAHORMEK, P
COSTELLO, RB
LADDU, AR
GOTTDIENER, JS
FLETCHER, RD
CIRCULATION, 1982, 65 (06) : 1119 - 1128
[35] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
Wermuth, L
EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
[36] Double-blind randomized placebo-controlled trial of sibutramine
Bray, GA
Ryan, DH
Gordon, D
Heidingsfelder, S
Cerise, F
Wilson, K
OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
[37] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, PHASE 2 TRIAL TO INVESTIGATE THE EFFECT OF BARUSIBAN ON IMPLANTATION IN IVF/ICSI PATIENTS.
Bosch, Ernesto
Aasted, Heidi
Klein, Bjarke M.
Arce, Joan-Carles
FERTILITY AND STERILITY, 2019, 112 (03) : E179 - E179
[38] Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial
Sun, Yuan-long
Yao, Yi-li
Jia, Mei-jun
Sun, Yuan-yuan
Li, He-lin
Ruan, Xiao-fen
Wang, Xiao-long
JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318
[39] Propafenone for the prevention of atrial fibrillation after cardiac surgery. A multi-center, randomized, double-blind, placebo-controlled clinical trial.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R111 - R111
[40] Efficacy of Qingpeng ointment (a Tibetan medicine) for acute gouty arthritis: a multi-center, randomized, double-blind, placebo-controlled trial
Ya-xi Shang
Shu-feng Wei
Ke-peng Yang
Yuan Liu
Su Wei
Xia Dong
Xin-chang Wang
Zhi-min Xie
Ru-lu Fang
Li-na Liang
Xiu-feng Li
Lei Xu
Mu-zhi Chen
Kai-xian Zhang
Ji-yong Huang
Le Wang
You-guo Yang
Hong-li Liao
Gui-e Xing
Yu-ping Zheng
Xiao-fen Li
Jing-lian Lin
Cheng-qian Shi
Yong-ping Zeng
Li-dan Mo
Fan Sun
Xiao-peng Li
Zhuo Zhang
Kai Chen
Zhao-chun He
Jian-ping Liu
BMC Complementary Medicine and Therapies, 24

← 1 2 3 4 5 →